Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer
Launched by IRCCS SAN RAFFAELE · Oct 3, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how common bone and metabolic problems are in patients who have thyroid cancer. Researchers want to understand how thyroid cancer might affect bones, particularly looking for issues like osteoporosis (weak bones) and vertebral fractures (broken bones in the spine). The study is currently recruiting participants who are at least 18 years old and have been diagnosed with thyroid cancer. They also need to have had specific imaging tests done before their surgery that show their spine's condition.
If you or someone you know is eligible and decides to participate, they will contribute to important research that could help improve care for future thyroid cancer patients. Participants will not have to undergo any new treatments as part of this study; instead, researchers will look back at existing medical records and data. Your involvement could help highlight the need for better monitoring and treatment for potential bone issues in thyroid cancer patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age ≥ 18 years
- • Histological diagnosis of Thyroid Carcinoma
- • radiological data from chest x-ray in lateral projection in the preoperative evaluation on which the vertebral morphometry
- • Signing of the informed consent
- Exclusion Criteria:
- • Subjects not falling within the previously described criteria are excluded
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported